APYX
Price
$1.69
Change
+$0.03 (+1.81%)
Updated
Jun 6, 04:54 PM (EDT)
Capitalization
47.46M
62 days until earnings call
CORBF
Price
$1.00
Change
-$0.00 (-0.00%)
Updated
Jun 2 closing price
Capitalization
154M
Interact to see
Advertisement

APYX vs CORBF

Header iconAPYX vs CORBF Comparison
Open Charts APYX vs CORBFBanner chart's image
Apyx Medical
Price$1.69
Change+$0.03 (+1.81%)
Volume$500
Capitalization47.46M
Global Cord Blood
Price$1.00
Change-$0.00 (-0.00%)
Volume$290
Capitalization154M
APYX vs CORBF Comparison Chart
Loading...
APYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APYX vs. CORBF commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APYX is a Hold and CORBF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (APYX: $1.67 vs. CORBF: $1.18)
Brand notoriety: APYX and CORBF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: APYX: 8% vs. CORBF: 267%
Market capitalization -- APYX: $47.46M vs. CORBF: $154M
APYX [@Medical Specialties] is valued at $47.46M. CORBF’s [@Medical Specialties] market capitalization is $154M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.52B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APYX’s FA Score shows that 0 FA rating(s) are green whileCORBF’s FA Score has 1 green FA rating(s).

  • APYX’s FA Score: 0 green, 5 red.
  • CORBF’s FA Score: 1 green, 4 red.
According to our system of comparison, CORBF is a better buy in the long-term than APYX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APYX’s TA Score shows that 4 TA indicator(s) are bullish.

  • APYX’s TA Score: 4 bullish, 5 bearish.

Price Growth

APYX (@Medical Specialties) experienced а +7.05% price change this week, while CORBF (@Medical Specialties) price change was +18.50% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.46%. For the same industry, the average monthly price growth was +5.98%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

APYX is expected to report earnings on Aug 07, 2025.

CORBF is expected to report earnings on Feb 27, 2023.

Industries' Descriptions

@Medical Specialties (+2.46% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CORBF($154M) has a higher market cap than APYX($47.5M). APYX YTD gains are higher at: 5.063 vs. CORBF (-33.333).
APYXCORBFAPYX / CORBF
Capitalization47.5M154M31%
EBITDA-18.11MN/A-
Gain YTD5.063-33.333-15%
P/E RatioN/A1.99-
Revenue52.3MN/A-
Total Cash43.7MN/A-
Total Debt38.5MN/A-
FUNDAMENTALS RATINGS
APYX vs CORBF: Fundamental Ratings
APYX
CORBF
OUTLOOK RATING
1..100
3429
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
63
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9661
PRICE GROWTH RATING
1..100
3878
P/E GROWTH RATING
1..100
10021
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

APYX's Valuation (57) in the Medical Specialties industry is in the same range as CORBF (63) in the Medical Or Nursing Services industry. This means that APYX’s stock grew similarly to CORBF’s over the last 12 months.

APYX's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as CORBF (100) in the Medical Or Nursing Services industry. This means that APYX’s stock grew similarly to CORBF’s over the last 12 months.

CORBF's SMR Rating (61) in the Medical Or Nursing Services industry is somewhat better than the same rating for APYX (96) in the Medical Specialties industry. This means that CORBF’s stock grew somewhat faster than APYX’s over the last 12 months.

APYX's Price Growth Rating (38) in the Medical Specialties industry is somewhat better than the same rating for CORBF (78) in the Medical Or Nursing Services industry. This means that APYX’s stock grew somewhat faster than CORBF’s over the last 12 months.

CORBF's P/E Growth Rating (21) in the Medical Or Nursing Services industry is significantly better than the same rating for APYX (100) in the Medical Specialties industry. This means that CORBF’s stock grew significantly faster than APYX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APYX
RSI
ODDS (%)
Bearish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 5 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
N/A
Declines
ODDS (%)
Bearish Trend 8 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
APYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JZ0.380.02
+6.47%
Jianzhi Education Technology Group Company Limited
SNFCA9.920.11
+1.12%
Security National Financial Corp.
IRDM26.530.19
+0.72%
Iridium Communications
EXPD111.15-0.42
-0.38%
Expeditors International of Washington
CHPT0.68-0.20
-22.49%
ChargePoint Holdings

APYX and

Correlation & Price change

A.I.dvisor indicates that over the last year, APYX has been loosely correlated with CORBF. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if APYX jumps, then CORBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APYX
1D Price
Change %
APYX100%
N/A
CORBF - APYX
36%
Loosely correlated
N/A
MKEAF - APYX
33%
Loosely correlated
N/A
RDNT - APYX
27%
Poorly correlated
+2.24%
MOVE - APYX
26%
Poorly correlated
-0.16%
IQV - APYX
26%
Poorly correlated
-0.36%
More

CORBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CORBF has been loosely correlated with SINT. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CORBF jumps, then SINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CORBF
1D Price
Change %
CORBF100%
N/A
SINT - CORBF
38%
Loosely correlated
-0.71%
APYX - CORBF
36%
Loosely correlated
N/A
MBOT - CORBF
33%
Loosely correlated
-2.90%
QTRX - CORBF
30%
Poorly correlated
-7.71%
BVS - CORBF
30%
Poorly correlated
-0.38%
More